These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31881391)

  • 1. Improving the quality conduct and efficiency of clinical trials with training: Recommendations for preparedness and qualification of investigators and delegates.
    Bechtel J; Chuck T; Forrest A; Hildebrand C; Panhuis J; Pattee SR; Comic-Savic S; Swezey T
    Contemp Clin Trials; 2020 Feb; 89():105918. PubMed ID: 31881391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More than a box to check: Research sponsor and clinical investigator perspectives on making GCP training relevant.
    Swezey T; McGuire FH; Hurley P; Panhuis J; Goldstein K; Chuck T; Dombeck C; Perry B; Brennan C; Phrsai N; Corneli A
    Contemp Clin Trials Commun; 2020 Sep; 19():100606. PubMed ID: 32817904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative.
    Fordyce CB; Malone K; Forrest A; Hinkley T; Corneli A; Topping J; Roe MT
    Contemp Clin Trials Commun; 2019 Dec; 16():100462. PubMed ID: 31701037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholders' recommendations for revising Good Clinical Practice.
    Corneli A; Forrest A; Swezey T; Lin L; Tenaerts P
    Contemp Clin Trials Commun; 2021 Jun; 22():100776. PubMed ID: 33997463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good Clinical Practice Training: Identifying Key Elements and Strategies for Increasing Training Efficiency.
    Arango J; Chuck T; Ellenberg SS; Foltz B; Gorman C; Hinrichs H; McHale S; Merchant K; Seltzer J; Shapley S; Wild G
    Ther Innov Regul Sci; 2016 Jul; 50(4):480-486. PubMed ID: 27390628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trials profile: professionals and sites.
    Paschoale HS; Barbosa FR; Nita ME; Carrilho FJ; Ono-Nita SK
    Contemp Clin Trials; 2010 Sep; 31(5):438-42. PubMed ID: 20601160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing clinical evidence by proactively building quality into clinical trials.
    Meeker-O'Connell A; Glessner C; Behm M; Mulinde J; Roach N; Sweeney F; Tenaerts P; Landray MJ
    Clin Trials; 2016 Aug; 13(4):439-44. PubMed ID: 27098014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Good Health Research Practice course: ensuring quality across all health research in humans.
    Henley P; Elango V; Horstick O; Ahmad RA; Maure C; Launois P; Merle C; Nabieva J; Mahendradhata Y
    Health Res Policy Syst; 2017 Mar; 15(1):28. PubMed ID: 28359338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European survey on national training activities in clinical research.
    Magnin A; Iversen VC; Calvo G; Čečetková B; Dale O; Demlova R; Blasko G; Keane F; Kovacs GL; Levy-Marchal C; Monteiro EC; Palmisano L; Pella D; Portolés Pérez A; Rascol O; Schmid C; Tay F; von der Leyen H; Ohmann C
    Trials; 2019 Oct; 20(1):616. PubMed ID: 31665085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative.
    Calis KA; Archdeacon P; Bain R; DeMets D; Donohue M; Elzarrad MK; Forrest A; McEachern J; Pencina MJ; Perlmutter J; Lewis RJ
    Clin Trials; 2017 Aug; 14(4):342-348. PubMed ID: 28503947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-risk trials for children and pregnant women threatened by unnecessary strict regulations. Does the coming EU Clinical Trial Regulation offer a solution?
    Knaapen M; Ploem MC; Kruijt M; Oudijk MA; van der Graaf R; Bet PM; Bakx R; van Heurn LWE; Gorter RR; van der Lee JH
    Eur J Pediatr; 2020 Aug; 179(8):1205-1211. PubMed ID: 32535715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A survey on French hospital physicians'certification to the good clinical practices].
    Fougerou-Leurent C; Chesnais J; Nekmouche S; Veislinger A; Le Saux M; Joumard C; Lorre V; Bellot C; Alleton N; Labourdette E; Marie C; Fin L; Bellissant E; Laviolle B
    Therapie; 2020; 75(6):537-542. PubMed ID: 32409207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing Clinical Research Professionals' Training and Qualifications (ECRPTQ): Recommendations for Good Clinical Practice (GCP) training for investigators and study coordinators.
    Shanley TP; Calvin-Naylor NA; Divecha R; Wartak MM; Blackwell K; Davis JM; Ellerbeck EF; Kieburtz K; Koziel MJ; Luzuriaga K; Maddox J; Needler NA; Murphy S; Pemberton K; Radovich C; Rubinstein EP; Selker HP; Tenaerts P; Unsworth K; Wilson K; Wright JE; Barohn R
    J Clin Transl Sci; 2017 Feb; 1(1):8-15. PubMed ID: 31660210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation.
    Nakamura K; Ozawa H; Shibata T; Ushirozawa N; Hata T; Okita N; Fuse N; Sato N; Ikeda K; Hanaoka H; Maruyama T; Wada M; Shimizu S; Kasai H; Yamamoto Y; Sakurai J; Todaka K; Tashiro S; Yamamoto H
    Ther Innov Regul Sci; 2022 Mar; 56(2):220-229. PubMed ID: 34787814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stakeholders' views on the most and least helpful aspects of the ICH E6 GCP guideline and their aspirations for the revision of ICH E6(R2).
    Dombeck C; Swezey T; Forrest A; Tenaerts P; Corneli A
    Contemp Clin Trials Commun; 2022 Oct; 29():100983. PubMed ID: 36111176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal, Regulatory, and Practical Issues to Consider When Adopting Decentralized Clinical Trials: Recommendations From the Clinical Trials Transformation Initiative.
    Apostolaros M; Babaian D; Corneli A; Forrest A; Hamre G; Hewett J; Podolsky L; Popat V; Randall P
    Ther Innov Regul Sci; 2020 Jul; 54(4):779-787. PubMed ID: 32557302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
    Zon R; Meropol NJ; Catalano RB; Schilsky RL
    J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.